FUS binds the CTD of RNA polymerase II and regulates its phosphorylation at Ser2
Jacob C Schwartz1, Christopher C Ebmeier, Elaine R Podell
1Howard Hughes Medical Institute.
Abstract:
Mutations in the RNA-binding protein FUS (fused in sarcoma)/TLS have been shown to cause the neurodegenerative disease amyotrophic lateral sclerosis (ALS), but the normal role of FUS is incompletely understood. We found that FUS binds the C-terminal domain (CTD) of RNA polymerase II (RNAP2) and prevents inappropriate hyperphosphorylation of Ser2 in the RNAP2 CTD at thousands of human genes. The loss of FUS leads to RNAP2 accumulation at the transcription start site and a shift in mRNA isoform expression toward early polyadenylation sites. Thus, in addition to its role in alternative RNA splicing, FUS has a general function in orchestrating CTD phosphorylation during RNAP2 transcription.
Insights
Fused in sarcoma (FUS) protein binds RNA polymerase II CTD, preventing abnormal phosphorylation. FUS loss causes transcription issues and altered mRNA, revealing its general role in transcription regulation.
Area of Science:
- Molecular Biology
- Neuroscience
- Genetics
Background:
- Mutations in the fused in sarcoma (FUS) protein are linked to amyotrophic lateral sclerosis (ALS).
- The precise physiological function of FUS in normal cellular processes remains unclear.
- Understanding FUS's role is crucial for insights into ALS pathogenesis.
Purpose of the Study:
- To elucidate the normal function of the FUS protein in gene transcription.
- To investigate the interaction between FUS and RNA polymerase II (RNAP2).
- To determine the consequences of FUS loss on RNAP2 activity and mRNA processing.
Main Methods:
- Chromatin immunoprecipitation assays to detect FUS binding to RNAP2.
- Analysis of RNAP2 C-terminal domain (CTD) phosphorylation patterns.
- RNA sequencing to assess mRNA isoform expression and polyadenylation site usage.
Main Results:
- FUS directly binds to the C-terminal domain (CTD) of RNA polymerase II (RNAP2).
- FUS prevents aberrant Ser2 hyperphosphorylation of the RNAP2 CTD across numerous human genes.
- Loss of FUS results in RNAP2 stalling at transcription start sites.
- FUS deficiency promotes a shift in mRNA expression towards earlier polyadenylation sites.
Conclusions:
- FUS plays a critical role in regulating RNAP2 CTD phosphorylation during transcription.
- Beyond alternative splicing, FUS has a general function in orchestrating transcription fidelity.
- These findings provide new insights into FUS's function and its implications in ALS.
Related Concept Videos
Transcription Initiation
The promoters and enhancers and their accessory proteins allow tight regulation of...
General Transcription Factors
Eukaryotic RNA Polymerases
All three eukaryotic RNAPs require specific transcription factors, of which the...
Transcriptional Regulation: Riboswitches
RNA Polymerase II Accessory Proteins
RNA Polymerase II Accessory Proteins


